Close

UPDATE: MKM Partners Downgrades Amarin Corporation (AMRN) to Neutral

Go back to UPDATE: MKM Partners Downgrades Amarin Corporation (AMRN) to Neutral

Amarin (AMRN) Says FDA Decision on ANCHOR SPA Delayed

January 15, 2014 4:06 PM EST

Amarin Corp Plc (NASDAQ: AMRN) announced today that the Division of Metabolism and Endocrinology Products (DMEP) within the U.S. Food and Drug Administration (FDA) notified the company today that a determination on Amarin's request for reconsideration of DMEP's October 2013 decision to rescind the ANCHOR... More

Amarin (AMRN) Ramps Ahead of Expected FDA Decision on ANCHOR SPA

January 15, 2014 1:19 PM EST

Shares of Amarin Corp Plc (NASDAQ: AMRN) are strong Wednesday ahead of expected news from the FDA on the company's ANCHOR SPA appeal.

The FDA said in December it plans to complete its review of Amarin's request to re-instate the ANCHOR... More